Reselute Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $3.39M

  • Investors
  • 7

Reselute General Information

Description

Operator of a medical technology company intended to treat orthopedic implant-related infections. The company designs, develops, and validates a proof of concept for an orthopedic spacer using technologies, enabling doctors to accelerate treatment and improve patient care.

Contact Information

Website
www.reselutemedical.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 701 West Main Street
  • Suite 410
  • Durham, NC 27701
  • United States
+1 (404)
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Vertical(s)
Digital Health, HealthTech, Life Sciences
Corporate Office
  • 701 West Main Street
  • Suite 410
  • Durham, NC 27701
  • United States
+1 (404)

Reselute Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Reselute Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series A) 22-Jul-2026 $3.39M Completed Generating Revenue
6. Grant 01-Jan-2025 Completed Generating Revenue
5. Early Stage VC (Series A) 21-May-2024 Completed Generating Revenue
4. Grant 01-Jan-2024 Completed Generating Revenue
3. Seed Round 18-May-2023 Completed Generating Revenue
2. Grant 01-Apr-2022 $255K Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Reselute’s complete valuation and funding history, request access »

Reselute Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Reselute’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Reselute Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • 1

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Reselute Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250248739-A1 Fluted and fenestrated intramedullary devices Pending 02-Feb-2024
WO-2025166122-A1 Fluted and fenestrated intramedullary devices Pending 02-Feb-2024
US-11883561-B1 Drug eluting implants and methods for producing the same Active 21-Oct-2022 A61L27/44

Reselute Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Reselute Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Band of Angels Angel Group Minority
Charlotte Angel Fund Angel Group Minority
U.S. Department of Health and Human Services Government
Western Skies Partners Venture Capital Minority
Duke Capital Partners Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

Reselute FAQs

  • When was Reselute founded?

    Reselute was founded in 2021.

  • Where is Reselute headquartered?

    Reselute is headquartered in Durham, NC.

  • What is the size of Reselute?

    Reselute has 7 total employees.

  • What industry is Reselute in?

    Reselute’s primary industry is Therapeutic Devices.

  • Is Reselute a private or public company?

    Reselute is a Private company.

  • What is the current valuation of Reselute?

    The current valuation of Reselute is .

  • What is Reselute’s current revenue?

    The current revenue for Reselute is .

  • How much funding has Reselute raised over time?

    Reselute has raised $6.7M.

  • Who are Reselute’s investors?

    Band of Angels, Charlotte Angel Fund, U.S. Department of Health and Human Services, Western Skies Partners, and Duke Capital Partners are 5 of 7 investors who have invested in Reselute.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process